323 related articles for article (PubMed ID: 29650788)
21. Identification of long non-coding RNA
Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565
[TBL] [Abstract][Full Text] [Related]
22. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Chao Y; Zhou D
Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695
[TBL] [Abstract][Full Text] [Related]
23. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
[TBL] [Abstract][Full Text] [Related]
24. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
26. Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma.
Han Y; Jiang W; Wang Y; Zhao M; Li Y; Ren L
BMC Cancer; 2022 Apr; 22(1):431. PubMed ID: 35443674
[TBL] [Abstract][Full Text] [Related]
27. Circulating exosome-derived bona fide long non-coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma.
Lu Y; Duan Y; Xu Q; Zhang L; Chen W; Qu Z; Wu B; Liu W; Shi L; Wu D; Yang Y; Sun D; Chen X
J Cell Mol Med; 2020 Jan; 24(2):1311-1318. PubMed ID: 31811749
[TBL] [Abstract][Full Text] [Related]
28. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
[TBL] [Abstract][Full Text] [Related]
29. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
30. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
31. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C
Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068
[TBL] [Abstract][Full Text] [Related]
32. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
34. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients.
Chen Y; Zhang J; Liu J; Wang J; Shi C; Lu L; Cheng X; Niu G; Zhang S
J Immunol Res; 2022; 2022():1817694. PubMed ID: 35224110
[TBL] [Abstract][Full Text] [Related]
35. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.
Li J; Wang X; Tang J; Jiang R; Zhang W; Ji J; Sun B
Cell Physiol Biochem; 2015; 37(2):687-96. PubMed ID: 26356260
[TBL] [Abstract][Full Text] [Related]
36. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma.
Guan W; Gao Z; Huang C; Fang M; Feng H; Chen S; Wang M; Zhou J; Hong S; Gao C
Glycoconj J; 2020 Apr; 37(2):231-240. PubMed ID: 31933068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
